1 documents found
Information × Registration Number 0120U104535, R & D request Title A 26-week open-label additional study evaluating the safety and tolerability of oral oral doses of zipraside in children and adolescents with type I bipolar disorder Head Skripnikov Andrii M., Доктор медичних наук Registration Date 23-10-2020 Organization Ukrainian medical stomatological Academy popup.description1 study evaluating the safety and tolerability of oral oral doses of zipraside in children and adolescents with type I bipolar disorder popup.nrat_date 2024-12-10 Close
search.res_rk
A 26-week open-label additional study evaluating the safety and tolerability of oral oral doses of zipraside in children and adolescents with type I bipolar disorder
Head: Skripnikov Andrii M.. A 26-week open-label additional study evaluating the safety and tolerability of oral oral doses of zipraside in children and adolescents with type I bipolar disorder. Ukrainian medical stomatological Academy. № 0120U104535
1 documents found

Updated: 2026-03-25


Роздрукувати цю сторінку